chrisvoncsefalvay/vaers-outcomes huggingface dataset:
17 years old was administered the 1st dose of Moderna COVID19 vaccine; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old was administered the 1st dose of Moderna COVID19 vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old was administered the 1st dose of Moderna COVID19 vaccine). On 04-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old was administered the 1st dose of Moderna COVID19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.; Sender's Comments: This report refers to a case of Product Administered to Patient of Inappropriate Age for mRNA-1273 (Lot number: 026B21A) with no associated AEs.
solar urticaria (maculopapular rash, mild itching) for first time in life, after first significant sun exposure the following spring. 2 consecutive days. resolved both days within 24- 48 hours. none since. back and scalp only (most intensely exposed areas)
Received 2nd dose in left deltoid at 4:30pm on 1/9/21.   Woke up at 3:30am with night sweats and cramping.  Discovered started menstruating on 1/10/21, 1 week early which was unusual for me.   Prior period was during 1st shot, 21 days prior.  Typical cycle is 26 days +/- 2 days and tracked on a phone app.   Woke up w/ same symptoms this AM (2/1/21) and got period early again, 21 days.
achiness for half of a day; he felt tiredness; This spontaneous case was reported by another health care professional and describes the occurrence of PAIN (achiness for half of a day) and FATIGUE (he felt tiredness) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A. and 026L20A.) for COVID-19 vaccination.     Concurrent medical conditions included Joint injury (Joint injuries). Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (achiness for half of a day). 03-Feb-2021, the patient experienced FATIGUE (he felt tiredness). On 04-Feb-2021, PAIN (achiness for half of a day) and FATIGUE (he felt tiredness) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   In concomitant medications GNC Joint supplement was also reported. No treatment details were reported.  Company Comment - This case concerns a 39 year old male patient with concurrent medical condition of joint injury, who experienced the non-serious unexpected event of pain and the expected event fatigue. The events occurred on the same day after receiving the second dose of mRNA-1273 vaccine. The rechallenge was not applicable. Patient's concurrent condition of joint injury remains a confounder. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2021-402807 (Patient Link).; Sender's Comments: This case concerns a 39 year old male patient with concurrent medical condition of joint injury, who experienced the non-serious unexpected event of pain and the expected event fatigue. The events occurred on the same day after receiving the second dose of mRNA-1273 vaccine. The rechallenge was not applicable. Patient's concurrent condition of joint injury remains a confounder. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
The patient was 11 years old at the time of vaccination, this was before approval for ages 5-11 to receive Pfizer.  The COVID-19 consent form had patient's age listed as 12, the patient also told the nurse she was 12 years old. The event occurred at School, the Dept of Health was providing a clinic there, giving COVID and flu vaccines. The patient had no adverse symptoms after receiving the vaccine.
Patient was complaining for feeling lightheaded and dizzy once she sat in the observation room. Took her to lay down and vitals taken BP was 148/93 pulse 86. Juice box given. With in two min patient sits up and and feeling fine. No dizziness.  She called uber for a ride home
Since patient quit getting the shot, patient have been flu free.; Initial information was received on 04-Dec-2020 regarding an unsolicited valid non-serious social media case from a consumer.  This case involves a patient with unknown demography who got flu (since quit getting the shot, patient have been flu free) (influenza), while he/she received vaccine INFLUENZA VACCINE.  Medical history, past medical treatments, vaccinations, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number and expiration date were not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza), unknown latency following the administration of INFLUENZA VACCINE.  Laboratory data was not reported.   It was not reported if the patient received any corrective treatment or not.  The outcome of the event was unknown.  There will be no information on the batch number for this case.
Severe muscle pain at injection site continues 3 months from administration. Pain is in muscle, not shoulder joint. No pain upon pressing externally on area, pain is only present when arm is moved under it's own power. Similar to a pulled muscle. Requested non-preservative vaccine. Shot given very low on arm muscle.
Patient reports pain in entire arm with 1 hour of receiving injection.  Large bruise to injection site. Pain continuing for more than 2 weeks following injection.
Onset of hives, mild at first, but worsening over next 24 hours.  Hives on torso and arms.  My daughter also said her heartbeat felt fast, though resting pulse is at 75 beats per minute.
Patient had febrile seizure the night of receiving vaccine. Patient seen in ER and discharged on Motrin and Tylenol.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age. On unknown date the patients were vaccinated with a dose of GARDASIL (lot number not provided). Route was not reported. The patient received a dose of GARDASIL that had been stored improperly. The nurse could not provide more detailed information. This is 1 of 3 reports from the same source (other case numbers 1212USA001482 and 1212USA001483). Additional information has been requested.
Low platelet counts from 145 to 120; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PLATELET COUNT DECREASED (Low platelet counts from 145 to 120) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cardiac operation NOS (Heart surgery five years ago). Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced PLATELET COUNT DECREASED (Low platelet counts from 145 to 120). At the time of the report, PLATELET COUNT DECREASED (Low platelet counts from 145 to 120) outcome was unknown.            Treatment information was not provided.
Pain in right arm and shoulder.  Sometimes it radiates down arm into the elbow and wrist.  It is not consistent.  Sometimes it is very light, and other times it is very severe.  I have also had a great deal of weakness in the right arm since the vaccination.
I did a home test on March 10, because my husband tested positive the day before. On that Friday I had a headache, congestion in my nose and I did a home test, and it was negative. The next day I had the same symptoms but somewhat worse and tested again and was negative and then one more and it was positive. I called the COVID-19 hotline and had instructed me to call urgent care. I went and told them about my test, and they took my vitals and then they prescribed me PAXLOVID with the open choice to either get it or not. I did decide to get the vaccine and it helped and today I took my last dose today.
she had all these red dots on her shin, they were itchy and she scratched them and they bled; she had all these red dots on her shin, they were itchy and she scratched them and they bled; She had all these red dots on her shin, they were itchy and she scratched them and they bled; This is a spontaneous report from a contactable consumer, reporting for herself. A 59-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number), via an unspecified route of administration at the left arm on 26Jan2021 12:00 at a single dose for COVID-19 immunization. Vaccination was done in a nursing home. Vaccine was not administered at military facility. Medical history included inflammation post-surgery for cataract and detached retina, from an unknown date and unknown if ongoing.  Concomitant medication included ketorolac tromethamine for inflammation post-surgery for cataract and detached retina. The patient previously received a flu shot on 29Dec2020 for immunization. The patient had the vaccine on Tuesday, 26Jan2021 and didn't look yesterday but today, 28Jan2021, she noticed capillaries at the surface of her skin, red dots, itchy and when she scratched them, they bled. She was asking if this was a side effect and should she be concerned about getting the second dose? It was reported that when she got out of the shower today 28Jan2021, she had all these red dots on her shin, they were itchy, and she scratched them and they bled. The area was about five or six inches long and inch to two inches wide. After she blotted it with her towel, it stopped bleeding and it has scabbed up pretty quickly. She mentioned she has pictures to provide. The patient was scheduled to receive the second dose of the vaccine on 16Feb2021. No hospitalization.No additional vaccines administered on same date of the Pfizer suspect. The outcome of the even itchy was recovered on 28Jan2021 while the outcome of all other events was recovering.  Information on the lot/batch number has been requested.
administered with an expired vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with an expired vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with an expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The HCP had reported that the vaccine was administered to an unknown number of patients and it was not known whether that were the patients 1st or 2nd doses. It was unknown to him if the vaccines were stored in the freezer or refrigerator prior its use.  Concomitant product use was not provided by the reporter. Treatment information was not provided by the reporter.
Big red circle around injection site; Itchy injection site; Warm to touch injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025120-2A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to touch injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I RECEIVED THE FIRST DOSE OF PFIZER VAC ON 3/27,  I HAD THE NORAMAL ARM PAIN AND CONGESTION AND HEADACHE ON 3-28,  ON 4-1 I STARTED HAVING CHILLS AND A RASH APPEARED ON LEFT SIDE OF MY BACK, BY SUNDAY 4-4, THE RASH HAD SPREAD FROM MY BACK AROUND MY LEFT SIDE AND ONTO MY STOMACH, I WENT TO URGENT CARE ON 4-4 AND WAS DIAGNOSED WITH SHINGLES.   I RETURNED TO URGENT CARE AGAIN ON 4-11 BECAUSE IT WAS NOT GETTING BETTER , AND THEN A VIDEO CONFERENCE WITH MY DR. OFFICE ON 4-13
Fever, chills, headache, fatigue, muscle pain, joint pain,  and nausea.  These side effects started ~10 hours after the second Covid vaccine and stopped ~22 hours after they started.
No additional AEs or PQC.; Caller reported VARIVAX administered after temperature excursion. Names of vaccines involved (including lot/exp) VARIVAX U022321  7/15/2023. Temperature 6F. Time frame 30 min; This spontaneous report has been received from an administrator referring a patient of an unknown age and gender.   The patient's pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant medications were not provided.   On 22-APR-2022, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) at dose 0.5 ml, subcutaneously, lot number U022321, expiration date on 15-JUL-2023 for prophylaxis (strength and frequency were not reported) that underwent a temperature excursion of 6 Fahrenheit degrees for 30 minutes (product storage error). There was no previous temperature excursion. No additional adverse events were reported.
Fever 101.4; Muscle aches; headache; chills; Dose number=1on 17Dec2020/ Dose number=2 on 05Jan2021; This is a spontaneous report from a contactable other healthcare professional (patient). A 33-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly on right arm at 09:30 AM on 05Jan2021 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly on left arm at 01:30 P.M on 17Dec2020 at single dose for Covid-19 immunization. The patient had no allergies to any medications, food, or other products. The patient experienced Fever 101.4 approximately 14 hours after getting second dose. Muscle aches, headache and chills at 11:00 PM on 05Jan2021. All events were reported as non-serious. The outcome of events was not recovered. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine; The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The outcome of events fever, muscle aches, headache and chills was not recovered.  Information on the lot/ batch number has been requested.
Mild pain upper right arm/shoulder/neck immediately after receiving vaccination. Pain worse next day.  Arm/shoulder pain resolved within a few days, neck pain persists - has not resolved.  Also developed swollen lymph node right side of neck 1 day after vaccination which remains swollen.  Saw FNP in regular provider office 2/04/21, no treatment recommended.   Episode of benign positional vertigo 1/21/21.  No history of this, FNP thought it could have been related to vaccination. Severe vertigo resolved after treatment, still have occasional mild vertigo episodes.
FOC reports pt having fever Saturday evening, sore arm, swelling on her upper L arm and as well the site to be hot to touch. No medication was given, no intervention treatment such as ICE was given as well.
Numbness on the arm where he was injected; Soreness and pain on the arm where he was injected; feverish; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HYPOAESTHESIA (Numbness on the arm where he was injected), VACCINATION SITE PAIN (Soreness and pain on the arm where he was injected) and PYREXIA (feverish) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included ASCORBIC ACID, BIOTIN, TOCOPHERYL ACETATE (BIOTIN GUMMY) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced INJECTION SITE HYPOAESTHESIA (Numbness on the arm where he was injected), VACCINATION SITE PAIN (Soreness and pain on the arm where he was injected) and PYREXIA (feverish). The patient was treated with IBUPROFEN ongoing since an unknown date for Adverse event, at a dose of 800 milligram three times a day. At the time of the report, INJECTION SITE HYPOAESTHESIA (Numbness on the arm where he was injected), VACCINATION SITE PAIN (Soreness and pain on the arm where he was injected) and PYREXIA (feverish) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-139069 (Patient Link).
Pt recvd 2 doses of Hep B vax in JUL91 & 22AUG91 & 1 wk following 2nd vax lab eval  revealed serum bilirubin 1.9, LDH 347, serum alkaline phsophatase 165 & nl SGOT & SGPT (lab eval in APR91 showed no abnormalities;
Flu shot was suppose to be given, but COVID vaccine was administered instead. Patient experienced flu-like symptoms for a day
About two months after receiving the second booster of the Pfizer Covid vaccine, I started to have cold like symptoms. On 09/21/2022, I lost my sense of taste and smell. I performed an at home test and they were positive for COVID-19. I did not reach out to my GP because my symptoms were never severe enough to go to the doctor. My sense of taste and smell were only gone for about 24-48 hours. After that, I was able to taste and smell again.
Received shots on 1/9/02 in the afternoon for a dog bite (also delayed immunizations, got only 2 DTAP's at this visit). Grandmother noted a blister on his injection site on the night of 1/10/02, followed by development of a warm, red and indurated area around it, the following morning. (3" X 2 1/2"). The pt also received tetanus immunoglobulin (given on the same day but in the Urgent Care because of it's unavailability in this clinic).
Sinusitis and ear infection within a few days of both doses. Now months of vertigo, hearing loss, ear fullness, ear popping.
5 days post vaccination, pain deep in the right side of neck. 8 days post vaccination  pain is so bad that I can't move my neck, 10 days post vaccination I am having trouble swallowing like something is pushing against the back of my esophagus mid neck and is very painful to swallow. 13 days post vaccination, went to my primary provider. STAT CT scan was done and diagnosed with retropharyngeal, prevertebral edema and a pocket of fluid pushing against my esophagus. No treatment done, provider had me discontinue the Otezla, 18 days post vaccination the pain was better and I could move my neck with much more ease. 22 days post vaccination and I could now swallow with out pain. Mammogram in April showed lymph involvement but it is believed to be from the covid vaccine also.
Pt recvd vax & devel a rash around inject site & a little down arm;
Booster; received the booster Pfizer covid vaccine dose on 27 Dec 2021,  5 months after the second doses which she received on 30 July 2021; received the booster Pfizer covid vaccine dose on 27 Dec 2021,  5 months after the second doses which she received on 30 July 2021; This is a spontaneous report received from contactable reporter(s) (Pharmacist) from medical information team.  A 46 -old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Dec2021 (Lot number: FD7218, Expiration Date: May2022) at the age of 46 years as dose 3 (booster), 0.3 ml single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (First dose , Date: 09Jul2021, NDC: 59267-1000-01, Lot: EW0196, Expiration: Sep2021, Site: Right arm), administration date: 09Jul2021, when the patient was 45 years old, for Covid-19 Immunization; Bnt162b2 (Second dose, Date: 30Jul2021, NDC: 59267-1000-01, Lot: FA7485, Expiration: Oct2021, Site: Right arm), administration date: 30Jul2021, when the patient was 45 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 27Dec2021, outcome "unknown", described as "Booster"; OFF LABEL USE (non-serious), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) all with onset 27Dec2021, outcome "unknown" and all described as "received the booster Pfizer covid vaccine dose on 27 Dec 2021,  5 months after the second doses which she received on 30 July 2021".  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a 19 year old female who on 06-AUG-2007 was vaccinated intramuscularly into the left arm with her first dose of Gardasil.  There was no concomitant medication.  On 20-AUG-2007 the patient broke out in bruises on both arms from the elbow to the shoulder.  The bruises in the arm pit areas became open sores.  The patient is recovering.  The patient's mother sought medical attention by calling the doctor's office.  The patient has a drug reaction/allergy to VICODIN.  Additional information has been requested.
Pt recv vax on 2/20/98; on same day pt exp screaming 3pm -> 10pm, to ER